# INDIVIOR PHARMACEUTICALS INC (INDV) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 45579U109
Page URL: https://superinvestorclub.com/stock/INDV
Last updated: 2026-08-29T13:47:15.129Z

## Summary

As of the most recent 13F filing period, INDIVIOR PHARMACEUTICALS INC (INDV) is held by 2 tracked superinvestors with an aggregate position value of $254.2M representing 0612721268181 shares.

## Top institutional holders (2)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Howard Marks](https://superinvestorclub.com/manager/87) | Oaktree Capital Management | 6127212 | $251.4M | 3.49% | 2026-06-30 |
| 2 | [Ray Dalio](https://superinvestorclub.com/manager/6) | Bridgewater Associates | 68181 | $2.8M | 0.01% | 2026-06-30 |

## Ownership history (quarter-over-quarter)

- 2026-03-31: 2 holders, $214.0M aggregate, 0698410237141 shares
- 2026-06-30: 2 holders, $254.2M aggregate, 0612721268181 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "INDIVIOR PHARMACEUTICALS INC (INDV) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/INDV), aggregating SEC 13F, Form 4, and congressional disclosures."